Hypoglycemic Effects of a Dietary Supplement With Inositols, Gymnema Silvestre, Alpha-lactalbumin and Zinc.

This study is aimed at evaluating the hypoglycemic effects of a dietary supplement that associates the properties of two inositols (myo-inositol and D-chiro-inositol) in the ratio 40:1 to Gymnema sylvestre, alpha-lactalbumin and zinc.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Metabolism Disorder Metabolic Diseases Nutritional and Metabolic Diseases

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sapienza University of Rome

Rome, RM, 00161, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

BMI between 30 and 35
Basal Glycemia between 100 and 125 mg/dl

Exclusion criteria

Diabetes diagnosis
Use of food supplements containing inositols, gymnema, alpha-lactalbumin and zinc
Intolerance to inositols, gymnema, alpha-lactalbumin and zinc

Treatment and study plan

EUDIAMET

Dietary Supplement

A combination of myo-inositol and D-chiro-inositol in the 40:1 ratio, Gymnema sylvestre, alpha-lactalbumin and zinc

Primary outcomes

Insulinemia

Time frame: Three time points: change in insulin levels from the baseline to three and six months

Reduction of systemic insulin levels

Sponsors and collaborators

Lead sponsor

Lo.Li.Pharma s.r.l

Industry

Registry information

Official study title

Hypoglycemic Effects of a Dietary Supplement That Combines the Properties of Myo-inositol and D-chiro-inositol With Gymnema Silvestre, Alpha-lactalbumin and Zinc.

Acronym: EUDIA_22

Important dates

Study start: 2022
Primary completion: 2022
Study completion: 2022
First posted: Apr 27, 2022
Registry last updated: Oct 13, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed